Douglas Pittman to Antineoplastic Agents
This is a "connection" page, showing publications Douglas Pittman has written about Antineoplastic Agents.
Connection Strength
0.303
-
Cisplatin resistance conferred by the RAD51D (E233G) genetic variant is dependent upon p53 status in human breast carcinoma cell lines. Mol Carcinog. 2009 Jul; 48(7):586-91.
Score: 0.190
-
Iterative conversion of cyclin binding groove peptides into druglike CDK inhibitors with antitumor activity. J Med Chem. 2015 Jan 08; 58(1):433-42.
Score: 0.069
-
Uracil in DNA: consequences for carcinogenesis and chemotherapy. Biochem Pharmacol. 2008 Sep 15; 76(6):697-706.
Score: 0.044